Last update of the site: December 16th, 2025
Liu Jinnan 1 et al. |
Abstract Background Limited studies demonstrated the relationships between first-trimester maternal dyslipidemia and adverse pregnancy-offspring complications. This investigation aimed to probe
Zhang Yueyu 1 et al. | BMC Nutrition
Abstract Background Hyperlipidemia is closely associated with chronic low-grade inflammation and metabolic disorders. The Dietary Inflammatory Index (DII) reflects the
Francisco Martínez‐Mardones 1 et al. | British Journal of Clinical Pharmacology
Abstract Aims Cardiovascular diseases (CVD) are the primary cause of death in Chile. Pharmacist‐led medication review with follow‐up (MRF) has
Katzmann Julius L. et al. | Current Cardiology Reports
Abstract Purpose of Review Low-density lipoprotein cholesterol (LDL-C) is one major cause of cardiovascular disease (CVD). In this review, we
Tassew Worku Chekol 1 et al. | BMC Cardiovascular Disorders
Abstract Introduction Dyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant
Daghistani Hussam 1 et al. | Lipids in Health and Disease
Abstract Long noncoding RNAs (lncRNAs) have emerged as critical regulators of lipid metabolism, playing pivotal roles in cholesterol biosynthesis, transport,
Yang Ningjing 1 et al. | Lipids in Health and Disease
Abstract Background Primary healthcare (PHC) plays a key role in hyperlipidemia (HL) management yet lacks adequate monitoring and feedback. This
